Gene · 7402
Papers3,966
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,966
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Magnetic Mitohormesis as a Potential Non-Invasive Restorative Therapy for X-Linked Muscular Dystrophies. | Int J Mol Sci | 2026 | 42737597 | PubTator, text mining | PubMed |
Polymer-specific nanoplastics trigger oxidative stress, inflammatory activation, and mitoepigenetic remodeling: in vitro and in silico evidence for MT-ND6-mediated mitochondrial complex I perturbation. | Front Toxicol | 2026 | 42733707 | PubTator, text mining | PubMed |
| Mercury Debt: Molecular Mechanisms and Exposome Mapping of Persistent Post-Amalgam Exposure. | J Appl Toxicol | 2026 | 42727934 | PubTator, text mining | PubMed |
| Curcumin attenuates DEHP-induced splenic immunotoxicity in chicks: involvement of Mfn2-mtROS-associated mitochondrial homeostasis. | Environ Pollut | 2026 | 42727807 | PubTator, text mining | PubMed |
| FTSJ3-Mediated 2'-O-Methylation of HSPA5 mRNA Stabilizes BOP1 via SUMOylation to Drive DRP1-Dependent Mitochondrial Fission and Fatty Acid Oxidation in Lung Squamous Cell Carcinoma. | Adv Sci (Weinh) | 2026 | 42711990 | PubTator, text mining | PubMed |
| Siglec-7 orchestrates mitochondrial dynamics and metabolic reprogramming to restrain human NK cell cytotoxic function. | J Biol Chem | 2026 | 42710663 | PubTator, text mining | PubMed |
| Exploring candidate biomarkers for nonobstructive azoospermia: A bioinformatics and machine learning approach. | Sci Prog | 2026 | 42709486 | PubTator, text mining | PubMed |
Targeting Mitochondrial PD-L1 O-GlcNAcylation to Sensitize HBV-Related HCC to Immunotherapy: Modulating Golgi-mitochondrial Crosstalk and mTOR/PGC-1α-Driven Mitochondrial Biogenesis to Overcome Resistance. | Int J Biol Sci | 2026 | 42694973 | PubTator, text mining | PubMed |
| Cancer-intrinsic SIRPα Signaling Triggers Mitochondrial Fission and Immune Tolerance to Promote TNBC Breast-to-Brain Metastasis. | Neuro Oncol | 2026 | 42675616 | PubTator, text mining | PubMed |
| EPS8 Differentially Regulates Antioxidant Defense and Mitochondrial Homeostatic Signaling in LNCaP and Enzalutamide-resistant LNCaP Cells. | Cancer Genomics Proteomics | 2026 | 42674824 | PubTator, text mining | PubMed |
| Decoding the bile acid-mitochondria axis: Implications for disease management and therapeutic opportunities. | Pharmacol Res | 2026 | 42668075 | PubTator, text mining | PubMed |
| Musculoskeletal (Mal)adaptations in Response to a > 30 000-km Running Challenge. | J Cachexia Sarcopenia Muscle | 2026 | 42666016 | PubTator, text mining | PubMed |
| Mitochondrial Homeostasis Mediates the Sustained Neuroprotection of CNTF-Chitosan Hydrogel Against NMDA-Induced Retinal Ganglion Cell Excitotoxicity. | Int J Mol Sci | 2026 | 42653205 | PubTator, text mining | PubMed |
| Propionic Acid Remodels Mitochondrial Metabolism in SH-SY5Y Cells. | Biology (Basel) | 2026 | 42651728 | PubTator, text mining | PubMed |
| Adaptor proteins recruit DRP1 into helical assemblies on mitochondria: Insights from super-resolution imaging. | Protein Cell | 2026 | 42640565 | PubTator, text mining | PubMed |
| Enhanced mitochondrial fission promotes chemosensitivity via SHP-1 activity in triple-negative breast cancer. | Mol Biol Rep | 2026 | 42640491 | PubTator, text mining | PubMed |
| Mitochondria-centered signalling in pulmonary hypertension: From metabolic reprogramming to vascular remodeling and right ventricular failure. | Cell Signal | 2026 | 42636946 | PubTator, text mining | PubMed |
| Efferocytosis regulatory factors in atherosclerosis: A preclinical systematic review. | Biochem Biophys Res Commun | 2026 | 42636768 | PubTator, text mining | PubMed |
| Mitochondrial-centric regulatory networks in MASLD: Integrating quality control, organelle interactions, and gut-liver communication. | Pharmacol Res | 2026 | 42628854 | PubTator, text mining | PubMed |
| Mitochondrial metabolic remodelling during bacterial infection: Molecular mechanisms, cellular consequences, and therapeutic opportunities. | Tissue Cell | 2026 | 42628190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7402/papers?page=2